Longitudinal growth on an everolimus-versus an MMF-based steroid-free immunosuppressive regimen in paediatric renal transplant recipients

Transplant International

Volumn 26, Issue 9, 2013, Pages 903-909

  Billing, Heiko ^a,b   Burmeister, Greta ^c   Plotnicki, Lukasz ^a   Ahlenstiel, Thurid ^c   Fichtner, Alexander ^a   Sander, Anja ^d   Höcker, Britta ^a   Tönshoff, Burkhard ^a   Pape, Lars ^c  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

children and adolescents; everolimus; longitudinal growth; mycophenolate mofetil; renal transplantation

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN A; EVEROLIMUS; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ARTICLE; BODY GROWTH; CATCH UP GROWTH; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DETERIORATION; ESTIMATED GLOMERULUS FILTRATION RATE; FEMALE; FIBROSING ALVEOLITIS; GLOMERULUS FILTRATION RATE; GROWTH RATE; GROWTH RETARDATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY CALCIFICATION; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MAINTENANCE THERAPY; MALE; NEPHROTOXICITY; OBSERVATIONAL STUDY; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SINGLE DRUG DOSE;

CHILDREN AND ADOLESCENTS; EVEROLIMUS; LONGITUDINAL GROWTH; MYCOPHENOLATE MOFETIL; RENAL TRANSPLANTATION;

ADOLESCENT; BODY HEIGHT; BONE DEVELOPMENT; CASE-CONTROL STUDIES; CHILD; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; PREDNISOLONE; PROSPECTIVE STUDIES; SIROLIMUS;

EID: 84882452607     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12148     Document Type: Article

References (25)

1. Gaumann A, Schlitt HJ, Geissler EK,. Immunosuppression and tumor development in organ transplant recipients: the emerging dualistic role of rapamycin. Transpl Int 2008; 21: 207.
2. Höcker B, Tönshoff B,. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option? Paediatr Drugs 2011; 13: 49.
3. Pape L, Ganschow R, Ahlenstiel T,. Everolimus in pediatric transplantation. Curr Opin Organ Transplant 2012; 17: 515.
4. Pape L, Offner G, Kreuzer M, et al,. De novo therapy with everolimus, low-dose ciclosporine A, basiliximab and steroid elimination in pediatric kidney transplantation. Am J Transplant 2010; 10: 2349.
5. Pape L, Lehner F, Blume C, Ahlenstiel T,. Pediatric kidney transplantation followed by de novo therapy with everolimus, low-dose cyclosporine A, and steroid elimination: 3-year data. Transplantation 2011; 92: 658.
6. Sanchez CP, He YZ,. Bone growth during rapamycin therapy in young rats. BMC Pediatr 2009; 9: 3.
7. Alvarez-Garcbox drawings light down and lefta O, Garcbox drawings light down and lefta-Lopez E, Loredo V, et al,. Rapamycin induces growth retardation by disrupting angiogenesis in the growth plate. Kidney Int 2011; 78: 561.
8. González D, García CD, Azõcar M, Waller S, Alonso A, Ariceta G,. Natalia mejía, fernando santos. growth of kidney-transplanted pediatric patients treated with Sirolimus. Pediatr Nephrol 2011; 26: 961.
9. Hymes LC, Warshaw BL,. Linear growth in pediatric renal transplant recipients receiving sirolimus. PediatrTransplant 2011; 15: 570.
10. Rangel GA, Ariceta G,. Growth failure associated with sirolimus: case report. Pediatr Nephro 2009; 24: 2047.
11. Plotnicki L, Kohl CD, Höcker B, et al,. The CERTAIN registry: a novel, web-based registry and research platform for pediatric renal transplantation in Europe. Transplant Proc 2013; 45: 1414.
12. Schwartz GJ, Munoz A, Schneider MF, et al,. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20: 629.
13. Fine RN,. Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: a historical perspective. Pediatr Nephrol 2010; 25: 725.
14. Pape L, Ehrich JH, Zivicnjak M, Offner G,. Growth in children after kidney transplantation with living related donor graft or cadaveric graft. Lancet 2005; 366: 151.
15. Prader A, Largo RH, Molinari L, et al,. Physical growth in Swiss children from birth to 20 years of age. Helv Paediatr Acta 1989; 43: 3.
16. Kromeyer-Hauschild K, Wabitsch M, Kunze D, et al,. Perzentile für den bodymass-index für das kindes- und jugendalter unter heranziehung verschiedener deutscher stichproben. Monatsschr Kinderheilkd 2001; 149: 807.
17. Tanner JM,. Growth and Adolescence, 2nd edn. Oxford: Blackwell Scientific Publications, 1962; 36 pp.
18. Rolland-Cachera MF, Cole TJ, Sempe M, et al,. Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 1991; 45: 13.
19. Greulich WW, Pyle SI,. Radiographic Atlas of Skeletal Development of the Hand and Wrist, 2nd edn. Stanford, CA: Stanford University Press, 1959: 256 pp.
20. Sis B, Mengel M, Haas M, et al,. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464.
21. Sarna S, Hoppu K, Neuvonen PJ, et al,. Methylprednisolone exposure, rather than dose, predicts adrenal suppression and growth inhibition in children with liver and renal transplants. J Clin Endocrinol Metab 1997; 82: 75.
22. Crowe A, Bruelisauer A, Duerr L, Guntz P, Lemaire M,. Absorption and intestinal metabolism of SDZ-RAD and rapamycin in rats. Drug Metab Dispos 1999; 27: 627.
23. ® Summary of Product Characteristics. New York, USA: Pfizer, 2011: 1 pp.
24. ® Basic Prescribing Information. Basel, Switzerland: Novartis Pharma AG, 2012: 1 pp.
25. Höcker B, Weber LT, Feneberg R, et al,. Improved growth and cardiovascular risk after late steroid withdrawal: 2-year results of a prospective, randomised trial in paediatric renal transplantation. Nephrol Dial Transplant 2010; 25: 617.